Briefly Bio, a London, UK-based techbio startup providing a tool to make lab work reproducible, raised $1.2M in funding.
The round was led by Compound VC, with participation from NP Hard, and Tiny VC.
The company intends to use the funds to expand operations and its development efforts.
Founded by Dr Katya Putintseva, Harry Rickerby and Staffan Piledahl, Briefly Bio is the tool to make lab work reproducible. It helps scientists capture, share their experiments clearly and consistently. Their software uses AI to convert existing experiment descriptions into this consistent format, while automatically filling in gaps and spotting errors. This helps capture the value of every experiment that is run, and enables scientists to learn from each other’s work.
FinSMEs
17/07/2024